(Q39937448)

15 September 2017

1 reference

title

The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Cardiology and cardiovascular medicine

9 February 2023

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

9 February 2023

author name string

D. G. Beevers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4592546

9 February 2023

J. J. Brown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4592546

9 February 2023

J. B. Ferriss

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4592546

9 February 2023

R. Fraser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4592546

9 February 2023

A. F. Lever

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4592546

9 February 2023

J. I. Robertson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4592546

9 February 2023

language of work or name

English

0 references

publication date

1 September 1973

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:0002870373900513?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

https://api.elsevier.com/content/article/PII:0002870373900513?httpAccept=text/plain

9 February 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

9 February 2023

published in

American Heart Journal

1 reference

15 September 2017

86

1 reference

15 September 2017

3

1 reference

15 September 2017

404-414

1 reference

PLASMA RENIN IN A CASE OF CONN'S SYNDROME WITH FIBRINOID LESIONS: USE OF SPINONOLACTONE IN TREATMENT.

15 September 2017

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

HYPOKALEMIA AND THE DIAGNOSIS OF HYPERTENSION

9 February 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

SUPPRESSION OF PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM

9 February 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Primary Aldosteronism with Suppressed Plasma Renin Activity Due to Bilateral Nodular Adrenocortical Hyperplasia

9 February 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypertension and aldosteronism in solitary adenomas and nodular hyperplasia of the adrenal cortex

9 February 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism

9 February 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The intercurrent hypertension of primary aldosteronism

9 February 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.

9 February 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Adrenal mineralocorticoids causing hypertension

9 February 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Adrenal cortical carcinoma producing solely mineralocorticoid effect

9 February 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Potassium deficiency of renal and adrenal origin

9 February 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Physiologic and surgical problems in the management of primary aldosteronism

9 February 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

9 February 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

PRIMARY ALDOSTERONISM DUE TO AN ADRENAL CARCINOMA

9 February 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Case of Probable Mineralocorticoid Excess Without Hypercortisolism Due to a Carcinoma of the Adrenal Cortex

9 February 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Pathology of primary aldosteronism

9 February 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Management of primary aldosteronism: evaluation of potassium and sodium balance, technic of adrenalectomy and operative results in 24 cases

9 February 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypermineralocorticoidism.

9 February 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hyperaldosteronism from adrenal carcinoma

9 February 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Aldosterone excess and adrenal carcinoma

9 February 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Carcinoma of the Adrenal Cortex with Hyperaldosteronism

9 February 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone

9 February 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

A new form of congenital adrenal hyperplasia

9 February 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

A case of glucocorticoid-responsive hyperaldosteronism

9 February 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Sodium and water depletion with acute malignant hypertension

9 February 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension.

9 February 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Plasma-renin and aldosterone secretion in hypertensive patients with renal or renal artery lesions.

9 February 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Plasma Renin Concentration and the Control of Blood Pressure in Patients on Maintenance Haemodialysis

9 February 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypertension and chronic renal failure

9 February 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypertension due to a renin-secreting renal tumour

9 February 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Renin levels in nephroblastoma (Wilms' tumour). Report of a renin secreting tumour

9 February 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Renin-secreting kidney tumours. A rare but remediable cause of serious hypertension

9 February 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Primary aldosteronism versus hypertensive disease with secondary aldosteronism

9 February 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

PLASMA RENIN CONCENTRATION IN HUMAN HYPERTENSION. 1. RELATIONSHIP BETWEEN RENIN, SODIUM, AND POTASSIUM

9 February 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Renin-angiotensin-aldosterone system during chronic thiazide therapy of benign hypertension

9 February 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Angiotensin II blood-levels in human hypertension

9 February 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity

9 February 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

A serial study in pregnancy of the plasma concentrations of renin, corticosteroids, electrolytes and proteins and of haematocrit and plasma volume

9 February 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Renin, angiotensin and aldosterone in human pregnancy and the menstrual cycle

9 February 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy

9 February 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

High blood pressure and oral contraceptives. Changes in plasma renin and renin substrate and in aldosterone excretion.

9 February 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypertension induced by oral contraceptives containing estrogen and gestagen. Effects on plasma renin activity and aldosterone excretion

9 February 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Blood-pressure in women after one year of oral contraception

9 February 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome

9 February 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypogonadism and mineralocorticoid excess. The 17-hydroxylase deficiency syndrome

9 February 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

17-hydroxylation deficiency in man

9 February 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Clinical and biochemical studies of a patient with a corticosterone-secreting adrenocortical tumour

9 February 2023

61

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

A liquorice extract with deoxycortone-like action

9 February 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Inhibition of the "mineralocorticoid" activity of licorice by spironolactone

9 February 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The clinical management of the diabetic adolescent

9 February 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

TREATMENT OF GASTRIC ULCER WITH CARBENOXOLONE SODIUM AND OESTROGENS.

9 February 2023

67

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

9 February 2023

Aldosterone

68

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypertension and Low Plasma Renin Activity: Presumptive Evidence for Mineralocorticoid Excess

9 February 2023

70

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The meaning of aldosteronism in hypertensive disease

9 February 2023

71

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hyporeninemic hypertension

9 February 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Renin Suppression in Hypertension in Relation to Body Fluid Volumes, Patterns of Sodium Excretion and Renal Haemodynamics

9 February 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone

9 February 2023

74

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypertension with aldosterone excess

9 February 2023

75

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The Control of Aldosterone Secretion and Its Relationship to the Diagnosis of Hyperaldosteronism

9 February 2023

76

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Plasma renin concentration in human hypertension . II. Renin in relation to aetiology

9 February 2023

79

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Aldosteronism in hypertension. The spironolactone response test

9 February 2023

80

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour

9 February 2023

81

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Effect of Spironolactone in Hypertensive Patients

9 February 2023

82

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma

9 February 2023

83

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin.

9 February 2023

85

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Changes of blood pressure, renin, and angiotensin after bilateral nephrectomy in patients with chronic renal failure

9 February 2023

87

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

THE EFFECT OF ANGIOTENSIN ON THE FUNCTION OF THE SEPARATE KIDNEYS IN PATIENTS WITH UNILATERAL RENAL ARTERY STENOSIS

9 February 2023

90

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

A Clinical Study of the Effects of an Aldosterone Antagonist (Aldactone-A) and a Thiazide Diuretic (Enduron) in Pregnancy

9 February 2023

92

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt.

9 February 2023

93

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Sodium diuresis induced by steroidal antagonists of aldosterone.

9 February 2023

94

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The effects of spironolactone and chlorthalidone on arterial pressure

9 February 2023

99

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The Vascular Effect of the Thiazide Diuretics

9 February 2023

100

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The role of diuretics in the management of hypertension

9 February 2023

101

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Spironolactone in hypertensive patients. Oligemic and antihypertensive effects

9 February 2023

102

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The long-term treatment of hypertension with thiazide diuretics

9 February 2023

104

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide

9 February 2023

105

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension

9 February 2023

106

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide

9 February 2023

107

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The effect of spironolactone on digital vascular reactivity in essential hypertension

9 February 2023

108

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Amiloride in primary hyperaldosteronism with chronic peptic ulceration.

9 February 2023

109

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes

9 February 2023

110

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

The use of amiloride hydrochloride in the correction of hypokalaemic alkalosis induced by diuretics

9 February 2023

111

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure

9 February 2023

113

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism?

9 February 2023

114

1 reference

https://api.crossref.org/works/10.1016/0002-8703(73)90051-3

9 February 2023

Identifiers

1 reference

15 September 2017

1 reference